Manuel F. Jiménez‐Navarro

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 369 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Clinical Impact of Intravascular Ultrasound Guidance in Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Disease

José M. de la Torre Hernández, José Antonio Baz Alonso, Fernando Alfonso Manterola et al. · JACC: Cardiovascular Interventions · 2014 · 234 citations · Full text

Medicine, Cardiology, Surgery +17

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

Javier Bermejo, Raquel Yotti, Rocío García‐Orta et al. · European Heart Journal · 2017 · 226 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

Mattie Lenzen, Eric Boersma, Wilma J.M. Scholte op Reimer et al. · European Heart Journal · 2005 · 191 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17